Bi-specific fusion proteins
US9982060B2 · kind B2 · utility
6Cited by
36References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2014 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Jul 11, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair damaged tissue. The bi-specific fusion proteins generally comprise: (a) a targeting polypeptide domain that binds to an ischemia-associated molecule; and (b) an activator domain that that detectably modulates the activity of a cellular network.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.